130
Participants
Start Date
May 26, 2017
Primary Completion Date
May 9, 2019
Study Completion Date
May 20, 2020
Gabapentin
Gabapentin (Neurontin®) is FDA-approved for the treatment of post-herpetic neuralgia and seizure disorder. Off-label uses include chronic refractory cough, neuropathy, hot flashes, restless leg syndrome, social anxiety disorder, and post-operative pain
Placebo
Methylcellulose placebo capsule
Planned Parenthood, Washington D.C.
MedStar Washington Hospital Center, Washington D.C.
Lead Sponsor
Society of Family Planning Research Fund
UNKNOWN
Medstar Health Research Institute
OTHER